Insider Buying: Maximus, Inc. (NYSE:MMS) CEO Buys 3,500 Shares of Stock

Maximus, Inc. (NYSE:MMS) CEO Bruce Caswell bought 3,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The stock was bought at an average cost of $70.64 per share, with a total value of $247,240.00. Following the completion of the acquisition, the chief executive officer now owns 275,929 shares in the company, valued at $19,491,624.56. This represents a 1.28 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Maximus Stock Down 0.2 %

Shares of NYSE MMS opened at $70.07 on Thursday. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a market cap of $4.22 billion, a price-to-earnings ratio of 14.01 and a beta of 0.73. Maximus, Inc. has a 12-month low of $69.72 and a 12-month high of $93.97. The firm’s 50-day simple moving average is $81.37 and its 200 day simple moving average is $86.30.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.71%. Maximus’s dividend payout ratio (DPR) is currently 24.00%.

Institutional Investors Weigh In On Maximus

A number of institutional investors and hedge funds have recently made changes to their positions in MMS. Wealth Enhancement Advisory Services LLC increased its position in Maximus by 4.5% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock worth $272,000 after purchasing an additional 136 shares during the period. Blue Trust Inc. boosted its stake in shares of Maximus by 201.5% in the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 262 shares during the last quarter. Raymond James & Associates boosted its stake in shares of Maximus by 9.6% in the 2nd quarter. Raymond James & Associates now owns 14,516 shares of the health services provider’s stock valued at $1,244,000 after purchasing an additional 1,275 shares during the last quarter. Summit Global Investments acquired a new stake in shares of Maximus during the 2nd quarter worth approximately $710,000. Finally, Bailard Inc. bought a new stake in shares of Maximus during the second quarter worth approximately $214,000. Institutional investors own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.